Across TCGA pan-cancer cohorts, LINC01345 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01345’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where LINC01345 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01345 is over-expressed in tumor, although a few such as BLCA and PRAD show the opposite, repressed pattern.

BLCA, PRAD, and LUAD are the cancer types where LINC01345 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01345 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	III,IV	−0.448	.001	8	view →
PRAD	All	All	−0.653	<.001	2	view →
LUAD	All	All	+0.109	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LINC01345 RNA expression & survival · all LINC01345 data types